Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma-Reference-Cited by-同舟云学术

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Published:2023-08-17 Issue:7 Volume:389 Page:589-601
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Mellinghoff Ingo K.¹,van den Bent Martin J.¹,Blumenthal Deborah T.¹,Touat Mehdi¹,Peters Katherine B.¹,Clarke Jennifer¹,Mendez Joe¹,Yust-Katz Shlomit¹,Welsh Liam¹,Mason Warren P.¹,Ducray François¹,Umemura Yoshie¹,Nabors Burt¹,Holdhoff Matthias¹,Hottinger Andreas F.¹,Arakawa Yoshiki¹,Sepulveda Juan M.¹,Wick Wolfgang¹,Soffietti Riccardo¹,Perry James R.¹,Giglio Pierre¹,de la Fuente Macarena¹,Maher Elizabeth A.¹,Schoenfeld Steven¹,Zhao Dan¹,Pandya Shuchi S.¹,Steelman Lori¹,Hassan Islam¹,Wen Patrick Y.¹,Cloughesy Timothy F.¹

Affiliation:

1. From Memorial Sloan Kettering Cancer Center, New York (I.K.M.); the Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (M.J.B.); Tel Aviv Medical Center, Tel Aviv University, Tel Aviv (D.T.B., S.Y.-K.), and the Davidoff Cancer Center, Rabin Medical Center, Petah Tikva (S.Y.-K.) — both in Israel; Sorbonne Université, Institut du Cerveau, Assistance Publique–Hôpitaux de Paris, Hôpitaux Universitaires la Pitié Salpêtrière–Charles Foix, Paris (M.T.), and Hôpital Neurologique Pierre...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2304194

Reference41 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

2. An Integrated Genomic Analysis of Human Glioblastoma Multiforme

3. IDH1andIDH2Mutations in Gliomas

4. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

5. IDH mutation impairs histone demethylation and results in a block to cell differentiation

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Where Do We (INDI)GO From Here?;International Journal of Radiation Oncology*Biology*Physics;2024-02

2. GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning;Scientific Reports;2024-01-25

3. AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper;Allergy;2024-01-24

4. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction;American Journal of Neuroradiology;2024-01-18

5. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis;Pathology International;2024-01-15